Found 26 results
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
2019
Kummer BR, Diaz I, Wu X, Aaroe AE, Chen ML, Iadecola C, Kamel H, Navi BB.  2019.  Associations between cerebrovascular risk factors and parkinson disease.. Ann Neurol. 86(4):572-581.
Seifan A, Ganzer CA, Ryon K, Lin M, Mahmudur R, Adolfo H, Shih C, Jacobs AR, Greenwald M, Isaacson RS.  2019.  Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases.. Curr Aging Sci. 11(4):242-249.
Schilling LPorcello, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, Rieder CRoberto de, Gauthier S, Palmini A, Rosa-Neto P.  2019.  Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.. Mol Neurobiol. 56(7):4916-4924.
Ishii M, Kamel H, Iadecola C.  2019.  Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer's Disease and Not Associated with Cognitive Decline or Incident Dementia.. J Alzheimers Dis. 67(1):257-263.
2018
Walters MJ, Sterling J, Quinn C, Ganzer C, Osorio RS, Andrews RD, Matthews DC, Vallabhajosula S, de Leon MJ, Isaacson RS et al..  2018.  Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.. BMJ Open. 8(11):e023664.
Berkowitz CL, Mosconi L, Rahman A, Scheyer O, Hristov H, Isaacson RS.  2018.  Clinical Application of APOE in Alzheimer's Prevention: A Precision Medicine Approach.. J Prev Alzheimers Dis. 5(4):245-252.
Isaacson RS, Ganzer CA, Hristov H, Hackett K, Caesar E, Cohen R, Kachko R, Meléndez-Cabrero J, Rahman A, Scheyer O et al..  2018.  The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.. Alzheimers Dement. 14(12):1663-1673.
Scheyer O, Rahman A, Hristov H, Berkowitz C, Isaacson RS, R Brinton D, Mosconi L.  2018.  Female Sex and Alzheimer's Risk: The Menopause Connection.. J Prev Alzheimers Dis. 5(4):225-230.
Mosconi L, Rahman A, Diaz I, Wu X, Scheyer O, Hristov HWebb, Vallabhajosula S, Isaacson RS, de Leon MJ, Brinton RDiaz.  2018.  Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study.. PLoS One. 13(12):e0207885.
Mosconi L, Walters M, Sterling J, Quinn C, McHugh P, Andrews RE, Matthews DC, Ganzer C, Osorio RS, Isaacson RS et al..  2018.  Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area.. BMJ Open. 8(3):e019362.
Berti V, Walters M, Sterling J, Quinn CG, Logue M, Andrews R, Matthews DC, Osorio RS, Pupi A, Vallabhajosula S et al..  2018.  Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults.. Neurology. 90(20):e1789-e1798.
2017
Isaacson R.  2017.  Is Alzheimer's Prevention Possible Today? J Am Geriatr Soc. 65(10):2153-2154.
Seifan A, Ganzer CA, Vermeylen F, Parry S, Zhu J, Lyons A, Isaacson R, Kim S.  2017.  Development and validation of the Alzheimer's prevention beliefs measure in a multi-ethnic cohort-a behavioral theory approach.. J Public Health (Oxf). 39(4):863-873.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.. PLoS One. 12(10):e0185926.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.. Neurology. 89(13):1382-1390.
2016
Schelke MW, Hackett K, Chen JL, Shih C, Shum J, Montgomery ME, Chiang GC, Berkowitz C, Seifan A, Krikorian R et al..  2016.  Nutritional interventions for Alzheimer's prevention: a clinical precision medicine approach.. Ann N Y Acad Sci. 1367(1):50-6.
2015
Berti V, Murray J, Davies M, Spector N, Tsui WH, Li Y, Williams S, Pirraglia E, Vallabhajosula S, McHugh P et al..  2015.  Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals.. J Nutr Health Aging. 19(4):413-23.
2014
Mosconi L, Murray J, Tsui WH, Li Y, Spector N, Goldowsky A, Williams S, Osorio R, McHugh P, Glodzik L et al..  2014.  Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD.. Neurology. 82(9):752-60.
Mosconi L, Murray J, Davies M, Williams S, Pirraglia E, Spector N, Tsui WH, Li Y, Butler T, Osorio RS et al..  2014.  Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study.. BMJ Open. 4(6):e004850.
2013
Mosconi L, Rinne JO, Tsui WH, Murray J, Li Y, Glodzik L, McHugh P, Williams S, Cummings M, Pirraglia E et al..  2013.  Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.. Neurobiol Aging. 34(1):22-34.
2012
Mosconi L, Tsui W, Murray J, McHugh P, Li Y, Williams S, Pirraglia E, Glodzik L, De Santi S, Vallabhajosula S et al..  2012.  Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease.. Neurobiol Aging. 33(3):624.e1-9.
2011
Mosconi L, de Leon M, Murray J, E L, Lu J, Javier E, McHugh P, Swerdlow RH.  2011.  Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease.. J Alzheimers Dis. 27(3):483-90.
2010
Mosconi L, Rinne JO, Tsui WH, Berti V, Li Y, Wang H, Murray J, Scheinin N, Någren K, Williams S et al..  2010.  Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.. Proc Natl Acad Sci U S A. 107(13):5949-54.
Mosconi L, Glodzik L, Mistur R, McHugh P, Rich KE, Javier E, Williams S, Pirraglia E, De Santi S, Mehta PD et al..  2010.  Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.. Biol Psychiatry. 68(10):913-21.
2009
Mosconi L, Mistur R, Switalski R, Brys M, Glodzik L, Rich K, Pirraglia E, Tsui W, De Santi S, de Leon MJ.  2009.  Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.. Neurology. 72(6):513-20.